Magnitude and Durability of the Antibody Response to mRNA-Based Vaccination Among SARS-CoV-2 Seronegative and Seropositive Health Care Personnel.

"Potential conflicts of interest. All authors: No reported conflicts."

"Financial support. This work was supported by a 2007 Gillings Gift from the UNC Gillings School of Global Public Health to A. E. A; the North Carolina Policy Collaboratory at the University of North Carolina at Chapel Hill with funding from the North Carolina Coronavirus Relief Fund established and appropriated by the North Carolina General Assembly to R. M. B.; the UNC School of Medicine to R. M. B.; a generous donation to the UNC School of Medicine by an anonymous donor to R. M. B.; the National Institute for Occupational Safety and Health (75D30121P10086 0000HCCK-2021 to A. E. A. and E. J. C.); the National Science Foundation (NSF 20-4353 to A. E. A.); the National Institutes of Health (R01 EB025021 to A. E. A.); National Center for Advancing Translational Sciences, National Institutes of Health (UL1TR001111), for use of the REDCap database; the National Heart, Lung, and Blood Institute (5T32HL007106 to E. J. C.); the National Institute of Allergy and Infectious Diseases (NIAID; 5F30AI160898 to D. R. Z.); the National Institute of Environmental Health Sciences (T32ES007018 to S. H.; F30ES032302 to E. K. L.); the NIAID (5K23AI141764 to R. M. B.; 5K24AI134990 to J. J. J.); the University of North Carolina at Chapel Hill Center for AIDS Research, an National Institutes of Health–funded program (P30AI050410 to B.E.S.-S.); and the National Cancer Institute (1U54CA260543 to L. P.) to produce and supply the necessary antigens for the study. Financial support."